Click on the protein name for more information about the protein.
The Score column is the predicted score of interaction between the two proteins
Click on the Evidence link to view a breakdown of the information about the predicted interaction.
Key | |
---|---|
Module Score | Databases |
Where interaction is observed in another database a link is provided: |
Protein 1 (?) | Protein 2 (?) | Name of Protein 2 | Module Scores (?) | Scores (?) | Evidence (?) | Database (?) | |||
---|---|---|---|---|---|---|---|---|---|
LNK | JAK2 | JAK2: Tyrosine-protein kinase JAK2 | 299.0 | Evidence | |||||
LNK | ZAP70 | ZAP70: Uncharacterized protein ZAP70 | 299.0 | Evidence | |||||
LNK | FYN | FYN: Proto-oncogene tyrosine-protein kinase Fyn | 299.0 | Evidence | |||||
LNK | KIT | KIT: Mast/stem cell growth factor receptor precursor | 224.0 | Evidence | |||||
LNK | CSF1R | CSF1R, FMS: Macrophage colony-stimulating factor 1 receptor precursor | 224.0 | Evidence | |||||
LNK | PDGFRB | PDGFRB: Beta-type platelet-derived growth factor receptor precursor | 224.0 | Evidence | |||||
LNK | FLT1 | FLT1, FLT, FRT: Vascular endothelial growth factor receptor 1 precursor | 224.0 | Evidence | |||||
LNK | PTK2B | PTK2B, FAK2, PYK2, RAFTK: Protein tyrosine kinase 2 beta | 119.0 | Evidence | |||||
LNK | CSK | CSK: Tyrosine-protein kinase CSK | 119.0 | Evidence | |||||
LNK | SYK | SYK: Tyrosine-protein kinase SYK | 119.0 | Evidence | |||||
LNK | ITK | ITK, EMT, LYK: Tyrosine-protein kinase ITK/TSK | 119.0 | Evidence | |||||
LNK | LCK | LCK: Proto-oncogene tyrosine-protein kinase LCK | 119.0 | Evidence | O | ||||
LNK | EPHB3 | EPHB3, ETK2, HEK2, TYRO6: Ephrin type-B receptor 3 precursor | 89.20 | Evidence | |||||
LNK | TEK | TEK, TIE2: Angiopoietin-1 receptor precursor | 89.20 | Evidence | |||||
LNK | CRKL | CRKL: Crk-like protein | 37.80 | Evidence | |||||
LNK | STAT5A | STAT5A, STAT5: Signal transducer and activator of transcription 5A | 37.80 | Evidence | |||||
LNK | TYRO3 | TYRO3, BYK, DTK, RSE, SKY: Tyrosine-protein kinase receptor TYRO3 precursor | 19.70 | Evidence | |||||
LNK | WAS | WAS, IMD2: Wiskott-Aldrich syndrome protein | 19.70 | Evidence | |||||
LNK | MAPK3 | MAPK3, ERK1, PRKM3: Mitogen-activated protein kinase 3 | 19.70 | Evidence | |||||
LNK | PRKCE | PRKCE, PKCE: Protein kinase C epsilon type | 19.70 | Evidence | |||||
LNK | SH2D2A | SH2D2A, SCAP, TSAD, VRAP: SH2 domain-containing protein 2A | 19.70 | Evidence | |||||
LNK | MAPK1 | MAPK1, ERK2, PRKM1, PRKM2: Mitogen-activated protein kinase 1 | 19.70 | Evidence | |||||
LNK | STAT5B | STAT5B: Signal transducer and activator of transcription 5B | 15.10 | Evidence | |||||
LNK | CBL | CBL, CBL2, RNF55: E3 ubiquitin-protein ligase CBL | 15.10 | Evidence | |||||
LNK | APS | SH2B2, APS: SH2B adapter protein 2 | 15.00 | Evidence | |||||
LNK | RASA1 | RASA1, RASA: Ras GTPase-activating protein 1 | 15.00 | Evidence | |||||
LNK | SLA | SLA, SLAP, SLAP1: SRC-like-adapter | 15.00 | Evidence | |||||
LNK | VAV1 | VAV1, VAV: Proto-oncogene vav | 15.00 | Evidence | |||||
LNK | SH3BP2 | SH3BP2: Uncharacterized protein SH3BP2 | 15.00 | Evidence | |||||
LNK | WASL | WASL: Neural Wiskott-Aldrich syndrome protein | 15.00 | Evidence | |||||
LNK | PIK3R2 | PIK3R2: Phosphatidylinositol 3-kinase regulatory subunit beta | 15.00 | Evidence | |||||
LNK | CTTN | CTTN, EMS1: Src substrate cortactin | 15.00 | Evidence | |||||
LNK | SLA2 | SLA2, C20orf156, SLAP2: Src-like-adapter 2 | 15.00 | Evidence | |||||
LNK | PTPN6 | PTPN6, HCP, PTP1C: Tyrosine-protein phosphatase non-receptor type 6 | 15.00 | Evidence | |||||
LNK | TUBA1 | TUBA4A, TUBA1: Tubulin alpha-4A chain | 13.00 | Evidence | |||||
LNK | CBLB | CBLB, RNF56, Nbla00127: E3 ubiquitin-protein ligase CBL-B | 13.00 | Evidence | |||||
LNK | SOS1 | SOS1: Son of sevenless homolog 1 | 13.00 | Evidence | |||||
LNK | CD247 | CD247, CD3Z, T3Z, TCRZ: T-cell surface glycoprotein CD3 zeta chain precursor | 9.92 | Evidence | |||||
LNK | PTPRC | PTPRC, RP11-553K8.4-001, hCG_1811178: Protein tyrosine phosphatase, receptor typ | 9.92 | Evidence | |||||
LNK | CD3E | CD3E, T3E: T-cell surface glycoprotein CD3 epsilon chain precursor | 9.92 | Evidence | |||||
LNK | CD79B | CD79B, B29, IGB: B-cell antigen receptor complex-associated protein beta-chain p | 9.92 | Evidence | |||||
LNK | STAT1 | STAT1: Signal transducer and activator of transcription 1-alpha/beta | 9.92 | Evidence | |||||
LNK | CD5 | CD5, LEU1: T-cell surface glycoprotein CD5 precursor | 9.92 | Evidence | |||||
LNK | FASLG | FASLG, APT1LG1, FASL, TNFSF6: Tumor necrosis factor ligand superfamily member 6 | 9.92 | Evidence | |||||
LNK | LCP2 | LCP2: Lymphocyte cytosolic protein 2 | 9.92 | Evidence | |||||
LNK | ACP1 | ACP1: Low molecular weight phosphotyrosine protein phosphatase | 7.59 | Evidence | |||||
LNK | BCAR1 | BCAR1, CAS, CRKAS: Breast cancer anti-estrogen resistance protein 1 | 6.14 | Evidence | |||||
LNK | GRAP | GRAP: GRB2-related adapter protein | 6.11 | Evidence | |||||
LNK | HPCA | HPCA, BDR2: Neuron-specific calcium-binding protein hippocalcin | 4.76 | Evidence | |||||
LNK | GRB10 | N/A | 4.68 | Evidence | |||||
LNK | PECAM1 | PECAM1: Platelet endothelial cell adhesion molecule precursor | 4.68 | Evidence | |||||
LNK | SH2D1A | SH2D1A, DSHP, SAP: SH2 domain-containing protein 1A | 3.18 | Evidence | |||||
LNK | SHC3 | SHC3, NSHC, SHCC: SHC-transforming protein 3 | 3.18 | Evidence | |||||
LNK | CASP3 | CASP3, CPP32: Caspase-3 precursor | 2.54 | Evidence | |||||
LNK | DEF6 | DEF6, IBP: Differentially expressed in FDCP 6 | 2.54 | Evidence | |||||
LNK | FRK | FRK, PTK5, RAK: Tyrosine-protein kinase FRK | 1.13 | Evidence | |||||
LNK | PTK2 | PTK2, FAK, FAK1: Focal adhesion kinase 1 | 1.13 | Evidence | |||||
LNK | SRC | SRC, SRC1: Proto-oncogene tyrosine-protein kinase Src | 1.13 | Evidence | |||||
LNK | TYK2 | TYK2: Non-receptor tyrosine-protein kinase TYK2 | 1.13 | Evidence | |||||
LNK | BTK | BTK, AGMX1, ATK, BPK: Tyrosine-protein kinase BTK | 1.13 | Evidence | |||||
LNK | MATK | MATK, CTK, HYL: Megakaryocyte-associated tyrosine-protein kinase | 1.13 | Evidence | |||||
LNK | TESK1 | TESK1: Dual specificity testis-specific protein kinase 1 | 1.13 | Evidence | |||||
LNK | BMX | N/A | 1.13 | Evidence | |||||
LNK | YES1 | YES1, YES: Proto-oncogene tyrosine-protein kinase Yes | 1.13 | Evidence | |||||
LNK | TEC | TEC, PSCTK4: Tyrosine-protein kinase Tec | 1.13 | Evidence | |||||
LNK | HCK | N/A | 1.13 | Evidence | |||||
LNK | INSL3 | JAK3: Tyrosine-protein kinase JAK3 | 1.13 | Evidence | |||||
LNK | JAK1 | 1.13 | Evidence | ||||||
LNK | ABL1 | ABL1, ABL, JTK7: Proto-oncogene tyrosine-protein kinase ABL1 | 1.13 | Evidence | |||||
LNK | FER | FER, TYK3: Proto-oncogene tyrosine-protein kinase FER | 1.13 | Evidence | |||||
LNK | TXK | TXK, PTK4: Tyrosine-protein kinase TXK | 1.13 | Evidence | |||||
LNK | PTK6 | PTK6, BRK: Tyrosine-protein kinase 6 | 1.13 | Evidence | |||||
LNK | ABL2 | ABL2, ABLL, ARG: Tyrosine-protein kinase ABL2 | 1.13 | Evidence | |||||
LNK | FGR | FGR, SRC2: Proto-oncogene tyrosine-protein kinase FGR | 1.13 | Evidence | |||||
LNK | LYN | LYN: Tyrosine-protein kinase Lyn | 1.13 | Evidence |